|
Woodcock Sees Big Impact from ‘Comparative Effectiveness’ Unit04/20/2010 A feature of the Administration’s recently-enacted
healthcare legislation calling for establishment of a Patient-Centered Outcomes Research Institute has received little attention
by the public, but may yet hold major implications for FDA and the pharmaceutical industry, according to CDER director Janet
Woodcock.... Read More
|
|
 |
|
| We bring the FDA to you |
|
|
| click image to view available FDA meetings |
Our Subscription Newsletters:
|
|
| Daily FDA and Industry Regulatory and Compliance News |
|
|
| The most authoritative FDA news analysis each month |
|
|
| Weekly easy to ready news capsules |
|
